Skip to main content

Nasdaq News

The Implied Analyst 12-Month Target For SYV

6 years 4 months ago
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itse
BNK Invest

Analysts Expect 11% Upside For The Holdings of MGV

6 years 4 months ago
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itse
BNK Invest

FXD's Holdings Could Mean 11% Gain Potential

6 years 4 months ago
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itse
BNK Invest

Implied VDE Analyst Target Price: $61

6 years 4 months ago
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itse
BNK Invest

Sum Up The Parts: EDOW Could Be Worth $26

6 years 4 months ago
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itse
BNK Invest

Here's My Single Best Investment Idea for June

6 years 4 months ago
Over the past couple of months, investors have been taken on the wildest roller-coaster ride in the stock market's history. The coronavirus disease 2019 (COVID-19) pandemic has created uncertainty and labor market disruption on a scale that's never been seen in the modern era. A
The Motley Fool

Karyopharm In Pursuit Of Wider Use Of Xpovio

6 years 4 months ago
(RTTNews) - After winning FDA nod for Xpovio in the treatment of relapsed or refractory multiple myeloma, Karyopharm Therapeutics Inc. (KPTI) is now awaiting the FDA decision on the same drug for another indication - i.e., in relapsed/refractory diffuse large B-cell lymphoma.
RTTNews

European Shares Rebound In Thin Holiday Trade

6 years 4 months ago
(RTTNews) - European stocks rose in thin holiday trade on Monday after U.S. President Donald Trump stopped short of threatening tariffs on China and a private survey showed that China's manufacturing sector moved into expansion territory in May.
RTTNews
Checked
21 minutes 39 seconds ago
This feed is responsible for generating the rss feed related to the topic latest article
Subscribe to Nasdaq News feed